Skip to content

Power Medical Interventions > Successful Demonstration of Incision-Free Bowel Surgery > Resection and Anastomosis via the Colon > New Techniques > Possible Widespread Adoption of Incision-Free NOTES Surgery > Natural Orifice Surgery Consortium for Assessment and Research’s NOSCAR > Natural Orifice Translumenal Endoscopic Surgery NOTES

Does the successful procedure further support the versatility and precision of the Intelligent Surgical Product Line? Are surgical techniques possible that allow for small bowel resection and anastomosis without abdominal incisions? Will the new technology accelerate the procedures related to Natural Orifice Surgery Consortium for Assessment and Research’s NOSCAR and Natural Orifice Translumenal Endoscopic Surgery NOTES?

powermedical.jpg

IIP > read on here > http://www.primenewswire.com…

…Power Medical Interventions(r), Inc. (Nasdaq:PMII), a leader in developing and commercializing Intelligent Surgical Instruments(tm), announced today that a team of doctors used the Company’s i-NOLC45 natural orifice linear stapler to successfully demonstrate a surgical technique that allows for small bowel resection and anastomosis without abdominal incisions. The live demonstration took place in San Francisco on July 12, 2008, at the Natural Orifice Surgery Consortium for Assessment and Research’s (NOSCAR) 3rd International Conference on Natural Orifice Translumenal Endoscopic Surgery(tm) (NOTES(tm)).

Tonia Young-Fadok, M.D., Colon & Rectal Surgery at the Mayo Clinic in Scottsdale, Nathaniel Soper, M.D., Chief of GI/Endocrine Surgery at Northwestern University Memorial Hospital, and Richard Rothstein, M.D., Chief of Gastroenterolgy at Dartmouth Hitchcock Medical Center, worked together to remove a portion of a small bowel through an opening in the colon, avoiding any incisions on the abdomen. After the team removed the small bowel, they proceeded to successfully reconnect the small bowel (anastomosis) using Power Medical’s i-NOLC45 natural orifice linear stapler in front of an audience of 300 surgeons, gastroenterologists, and industry professionals.

NOTES is a new minimally invasive surgical approach that involves passing surgical instruments through one of the body’s natural orifices, such as the mouth, vagina or rectum, to remove a diseased organ or tissue.

Operating solely through the body’s natural orifices eliminates external incisions and scarring, and reduces recovery time, physical discomfort, and healthcare costs when compared to traditional and laparoscopic surgeries.

Power Medical’s Intelligent Surgical Instruments are computer-assisted, power-actuated endomechanical instruments that surgeons use for cutting, stapling and tissue manipulation in a variety of procedures in open surgery and minimally invasive surgery. The Company believes that compared to conventional endomechanical devices, its Intelligent Surgical Instruments offer greater precision and consistency, superior compressive force, improved access to anatomical sites and enhanced ease of use. PMI’s Intelligent Surgical Instruments have been used in over 30,000 surgical procedures worldwide…

STOMAPHYX PLUS > Next-Generation Device > Stronger suction capable > Natural Orifice Surgery NOS > Transoral incisionless surgery > EndoGastric Solutions EGS > Incisionless transoral procedures > Treatment of upper gastrointestinal conditions > Gastroesophageal reflux disease GERD > GI conditions > EsophyX > Leading-edge NOS natural orifice surgery products > Proprietary NOS platform technology

Does the use of a standard endoscope permit easier clearing of the visual field? Does the higher resolution image allow for even greater precision? Is StomaphyX the future of surgery, and NOS the next step beyond laparoscopy?

esophyx.jpg

IIP > read on here > http://www.endogastricsolutions.com…

…EndoGastric Solutions (EGS), the world leader in natural orifice surgery (NOS) products and procedures, today announced the launch of its next-generation StomaphyX® device, StomaphyX Plus.StomaphyX Plus follows the launch of the StomaphyX device by just over a year and is the result of EGS’ research and development efforts to advance the device to better meet the needs of the surgical community.

It features a number of significant enhancements, including a quick-loading fastener cartridge and accommodating the use of a larger, more standard endoscope…

Commenting on the overall performance of StomaphyX Plus, Todd Overcash, MD, laparoscopic surgeon at Munroe Regional Medical Center, Ocala, Florida, and the first surgeon to try the device, said, “StomaphyX Plus made the procedure even easier to perform and reduced my procedure time to less than 15 minutes.”

Like its predecessor, StomaphyX Plus is a breakthrough transoral “incisionless” surgical device introduced into the body through the mouth, rather than through an abdominal incision. The procedure is performed under constant visualization by an endoscope inserted down the central shaft of the StomaphyX Plus device. Once inside the stomach, a small section of the stomach wall is suctioned up into the device and fastened with a permanent suture-like fastener creating a large fold called a plication. As many as 10 to 20 plications can be created depending on the needs of the patient. The benefits of incisionless surgery include a much lower risk of postoperative complications. It can also significantly reduce hospital stay and patient discomfort and provide improved patient recovery and higher patient satisfaction…

Biocompatible microneedle > Painless needle > Mimics mosquito’s bite > Microneedle > Draw blood > Inject drugs > Glucose-level monitor > Inner diameter of around 25 microns > External diameter of 60 microns

Does the working principle of this device follow the discovery that in a well-designed microneedle, surface tension forces may overcome resistance from friction? Can blood be drawn up blood with unprecedented efficiency? When will it be possible to fabricate the device in mass production?

mosquito.jpg

IIP > read on here > http://technology.newscientist.com…

A painless “microneedle” that mimics the way a female mosquito sucks blood has been built by engineers in India and Japan. The needle could be used to draw blood, inject drugs, and as a glucose-level monitor for diabetics.

A female mosquito sucks blood by flexing and relaxing certain muscles in its proboscis. This creates suction (or negative pressure) that draws blood into its mouthparts.

The new biocompatible microneedle, designed by Suman Chakraborty of the Indian Institute of Technology in Kharagpur and Kazuyoshi Tsuchiya of Tokai University in Kanagawa is based on the same principle.

In this case, the sucking action is provided by a microelectromechanical pump, which works using a piezoelectric actuator attached to the needle.

Contrary to popular belief, a mosquito bite does not hurt. It is the anticoagulant saliva that the creature injects to stop your blood clotting that causes inflammation and pain.
Snap safe

The new needle has an inner diameter of around 25 microns and an external diameter of 60 microns, which is about the same size as a mosquito’s mouthpart. Its size and the fact that it works by suction, makes it painless. To compare, a conventional syringe needle has an outer diameter of around 900 microns.

In contrast to previous microneedles, which were made of silicon dioxide, the new device is robust because it is made of stronger titanium and related alloys, which dramatically reduces the risk of it snapping during injections.

The needle is also strong enough to penetrate as far as 3 millimetres into skin and reach capillary blood vessels.

Its size compared to earlier models also means that surface tension effects are exploited further, and the same capillary flow that draws water up into trees helps draw blood into the microneedle.

The researchers have calculated that their needle can extract 5 microlitres of blood per second. This volume is sufficient for measuring blood-sugar levels in diabetics using a glucose sensor that can be attached to the needle in a “wristwatch” design.
Production challenges

The design uses a shape-memory alloy to drive the needle into skin and a micro-pump for delivering drugs. The latter could be used to inject insulin (or other drugs) into the patient when required…

Chakraborty and Tsuchiya hope to commercialise their needle, but there are still some challenges to overcome, including cost, scaling up the fabrication method, and making it more user-friendly…

Anastomotic leak rate < Outcome for laparoscopic intra-corporeal stapled anastomosis > Patients undergoing laparoscopic surgery > Primary colonic left-sided intracorporeal stapled anastomosis > Identify the clinical anastomotic leak rate > Laparoscopic colorectal surgery

Are the factors for this study patient demographics, indication for operation, procedure performed, height of anastomosis, leak rate and the outcome, inpatient stay, mortality, rate of defunctioning stomas, and rate of conversion to open procedure? Are intra-operative air leak rare in these patients? Does this study demonstrate that the anastomotic leak rate from intra-corporeal laparoscopic anastomosis is no greater than for open surgery or laparoscopic surgery with extra-corporeal anastomosis?

colorectal.jpg

IIP > read on here > http://www.journalofmas.com…

…Following introduction of laparoscopic minimally invasive surgery in 1985… the first reports of laparoscopic colectomy appeared in the 1990’s… However, until recently laparoscopic colorectal surgery has not been widely accepted and remains available to only a minority of patients. This is partly due to the relatively small number of laparoscopically trained colorectal surgeons and partly due to the lack of evidence documenting the complication rate of the laparoscopic approach in colorectal surgery to convince all colorectal surgeons to adopt it. Colorectal anastomotic leak remains one of the most feared post-operative complications particularly after anterior resection of the rectum with the shift from abdomino-peritoneal resections to total mesorectal excision and primary anastomosis.

Literature states various incidence rates of anastomotic leak in laparoscopic colorectal surgery, ranging 5-12% … This compares with anastomotic leakage of 1.3-18% following open sigmoid and rectal cancer excision… We have taken as our standard the anastomotic leak rate in The Wessex Colorectal Cancer Audit for patients in our region of 5.5% for major leak…

Performing proximal defunctioning stoma has been proposed to significantly reduce the effects of anastomotic leakage, if not reduce the anastomotic leak rate itself, in open surgery… but no similar data exists for the laparoscopic colonic surgery. On the other hand, no significant advantage in temporary defunctioning has been demonstrated in open surgery… Therefore using a stoma for laparoscopic surgery that would not have been used for open surgery would have negated the anticipated advantages of laparoscopic surgery, including shorter hospital stay, better cosmesis, briefer use of parenteral narcotics and oral analgesics, faster resumption of normal function…and has been avoided in our practice.

Whilst many investigators have previously assessed laparoscopically-assisted extracorporeal stapled anastomoses; our audit reviews intracorporeal anastomoses and is aimed at assessing the safety of laparoscopic anastomosis thereby reducing anxiety regarding the possibility of a higher rate of anastomotic leakage for laparoscopic than open anastomosis…

A prospective audit of all patients undergoing laparoscopic surgery with the intention of primary colonic left-sided intracorporeal stapled anastomosis to identify the anastomotic leak rate on an intention to treat basis.

Between January 2003 and August 2006, all patients undergoing laparoscopic colorectal surgery resulting in left-sided stapled anastomosis were included. All operations were conducted by the same surgical team with the same pre-operative preparation and surgical technique. The factors analysed for this audit were patient demographics (age and sex), indication for operation, procedure performed, height of anastomosis, leak rate and the outcome, inpatient stay, mortality, rate of defunctioning stomas, and rate of conversion to open procedure. Results for anastomotic leakage were compared with known results from the Wessex Colorectal Audit for open colorectal surgery.

Bowel preparation involved clear fluids for 24h and 2 phosphate enemas pre-operatively. After mobilisation of the left colon the bowel was tied distal to the tumour with a nylon tape to allow washout of the rectal stump. Division of the colon or rectum was performed distal to the encircling tape using the Ethicon ETS Flex 45 mm or Echelon 60 mm. Firings of these guns were limited to a maximum of two cartridges to whenever possible. An incision was made in the left iliac fossa and the Alexis wound retractor inserted to facilitate delivery of the bowel and to protect the wound edges from exfoliated malignant cells. The marginal vessels were divided between clips and ligated, a non-crushing bowel clamp applied proximally and the left colon transacted by scalpel. The anvil of the Ethicon 29 mm CDH gun was placed into the end of the bowel and a hand sewn purse string sutured extracorporeally with Prolene 2 ‘O’ suture. The left iliac fossa wound was secured by lifting and clamping the wound retractor and the gun passed per-anum. Anastomosis was performed intracorporeally under direct camera vision with the trocar of the gun being brought through the rectal stump at the site of joining of the two cross staple lines to excise this area of potential weakness. All anastomoses were air tested. An indirect assessment was done by inspecting both the proximal and distal donuts. If there was an air leak or an incomplete donut, a defunctioning ileostomy was used…

Eighty-four patients (49 females, 35 males; median age 70 years, range 19 - 89 years) underwent colonic procedures with left-sided intracorporeal stapled anastomosis. Of these, 15 patients (17.9%) underwent reversal of Hartmann’s operation, 54 (64.3%) anterior resection, 11 (13.1%) Sigmoid colectomy, 2 (2.4%) left hemicolectomy, 1 (1.2%) total colectomy, 1 (1.2%) reversal of end ileostomy… Thirty-eight operations (56%) were performed to resect bowel cancer and 30 (44%) were for benign disease.

The planned laparoscopic procedure with intracorporeal stapled anastomosis without defunctioning was completed in 73 patients.

Sixty nine patients recovered without significant post-operative complications. One patient was returned to theatre due to an intra-abdominal haemorrhage. One patient suffered a myocardial infarction.

Five cases (6%) were converted to open surgery. Reasons for conversion included: small bowel hernia into colostomy site that could not be mobilized, diathermy failure, inability to get stapler across rectum below tumour, excessive adhesions, and excessive oozing from dissection field.

Seven patients (8.3%) had a primary defunctioning stoma.

Intra-operative air leak was evident in one patient, whose anastomosis at 15 cm was oversewn
intracorporeally and defunctioned by ileostomy. Subsequent gastrograffin enema X-ray study showed no leakage at six weeks post-operatively and the stoma was closed without complication. In addition, six other patients were defunctioned, and four were subsequently reversed to date. Three patients, two with an anastomosis at 4 cm and one at 6 cm had an incomplete donut and were defunctioned although there was no evidence of air leak on testing. Inspection of these anastomoses by proctoscopy approximately six weeks later was satisfactory and the stomas were closed uneventfully without radiological confirmation. One anastomosis was defunctioned as it was judged to be under too much tension despite mobilisation of the splenic flexure back to the middle colic artery and one due to too many firings of the cross stapling gun leaving a potential weakness outside the circumference of the TLH donut. One patient was awaiting liver resection for hepatic secondaries, and required an uncomplicated recovery from colectomy. Thus the very low anastomosis at 4 cm was defunctioned to minimize the risk. One patient was converted to open surgery due to excessive generalised ooze compromising laparoscopic vision in the pelvis and was subsequently defunctioned after an open anastomosis. The median height of anastomosis was 12 cm, range 4-18 cm from anal verge as measured either intra-operatively, or by rigid sigmoidoscopy post-operatively…

Two patients underwent re-operation for complications and had an end stoma formed: An 82-year-old patient with malignant disease whose anastomosis was at 6 cm leaked on the third post-operative day. The patient was returned to theatre within six hours of becoming unwell, the anastomosis was disconnected and brought out as an end-stoma but the patient died of overwhelming sepsis within 48h of re-operation. A 55-year-old patient with an anastomosis at 15 cm developed a colo-vesical fistula following a reversal of Hartmann’s operation.

The anastomosis was subsequently defunctioned and brought out as an end stoma.

Thirty-day mortality was 50% in the leak group and 0% in the non-leak group.

The median post-operative stay for all 84 patients including those defunctioned, those converted to open surgery and those with complications was six days, range 2-23…

Since the introduction of laparoscopic surgery, there were concerns about an increased risk of various complication compared to open procedures. In particular, these included potential staging inaccuracies, inadequacy of resection, anastomotic leaks, and altered models of tumour dissemination. The technique of fashioning the anastomosis is thought to have considerable influence on the rate of anastomotic failure (hand-sewn vs. stapled: 5.8% vs. 2.3%)… In our study only a stapled technique was used. The height of anastomosis has been shown to affect the incidence of anastomotic leak… In this study a fatal clinical leak occurred in a relatively low (6 cm) anastomosis. The colo-vesical fistula that developed at 15 cm from the anal margin after reversal of Hartmann’s operation is likely to have been due to bladder becoming interpostioned between the anvil and the body of the anastomosis gun during closure rather than failure of an intact anastomosis.

The significance of air testing was stressed … In our study, we air tested the anastomoses and inspected the doughnuts peri-operatively. Only one patient had an air leak and this was successfully treated intraoperatively. Whether a defunctioning stoma is necessary in this situation is not known.

While this study did not include radiological assessment of the integrity of anastomoses postoperatively, we believe that only the clinically apparent anastomotic leaks are important. There were only two clinically evident anastomotic leaks postoperatively (2.9%). This compares favourably to the rates of anastomotic leakage of 1.3-17.7% in open procedures elsewhere … and 5.5 % in our own region… The rate of anastomotic leakage reported from laparoscopic procedures of 2.5-12% previously rarely relates to intra-corporeal anastomosis and usually includes patients with right sided anastomosis…

Our results suggest that the anastomotic leak rate for left-sided colorectal stapled anastomosis is no worse than that for open surgery and therefore the decision-making process for defunctioning stoma should be guided by the same principles as in open surgery. Defunctioning is recommended when technical difficulties in completion of the anastomosis are encountered or in the presence of multiple adverse factors… These include level of anastomosis, gender (males being at higher risk), pre-operative pelvic irradiation, intraoperative adverse events, inadequate bowel preparation or comorbid conditions associated with poor tissue healing… In our study, the rate of defuctioning was significantly influenced by the level of anastomosis: 83% in 0-5 cm group and 9.1% in 6-10 cm group ( P <0.01) … We have used defunctioning stomas in seven patients (8.3%) with no patient that was defunctioned having any clinical evidence of leakage. The one patient that had an anastomotic leak and died might have benefited from a defunctioning stoma, although there were no adverse features at the time of surgery to indicate this.

The rate of conversion to open surgery has been reported between 5.6 and 29%… Although conversion to open surgery should not be considered as a complication, but a prudent choice made to ensure the safety of procedure, our conversion rate of 6% appears at the lower end of expected range. Our results suggest that the conversion rate is not significantly affected by the level of anastomosis…

It was observed that there was a trend towards the postoperative stay becoming shorter as experience accumulated…

We believe that this study demonstrates that the anastomotic leak rate from intracorporeal laparoscopic anastomosis is no greater than for open surgery or laparoscopic surgery with extra-corporeal anastomosis…

Stent-graft > EVAR > New findings on abdominal aortic aneurysm AAA > Mortality > Endovascular technology > Hospital volume > Proportion of AAA repaired with EVAR > Increased from 27% to 39%

Did the introduction of endovascular (EVAR) technology change the relationship of hospital volume to mortality with abdominal aortic aneurysm repair?Are higher-volume hospitals are more likely to use the endovascular approach? Is the greater use of the endovascular procedure at high-volume hospitals accounting for the difference in mortality between high-and low-volume hospitals?

fenestratedendograft.jpg

IIP > read on here > http://www.newsrx.com…

…New research, ‘Endovascular technology, hospital volume, and mortality with abdominal aortic aneurysm surgery,’ is the subject of a report. According to recent research from the United States, “To determine whether the introduction of endovascular technology changed the relationship of hospital volume to mortality with abdominal aortic aneurysm repair. Data from all hospitals in the United States that performed abdominal aortic aneurysm surgery on Medicare patients from 2001 to 2003 were obtained from the national Medicare database.”

“The primary outcome variable was death <or=30 days of operation or before hospital discharge. We determined the effect of total hospital volume on operative mortality for all types of repair and for endovascular and open repair separately. All analyses were adjusted for patient risk using logistic regression. The proportion of abdominal aortic aneurysms repaired with an endovascular approach increased from 27% to 39% during the 3-year study period. Hospital volume was significantly related to operative mortality in all comparisons. Mortality rates were 80% higher at hospitals in the lowest vs the highest quartile of total volume (odds ratio [OR], 1.81; 95% confidence interval [CI], 1.62-2.04) when considering all types of repair together. A similar relationship between total hospital volume and mortality was found when separately examining open repair (OR, 1.52; 95% CI, 1.33-1.73) and endovascular repair (OR, 1.68; 95% CI, 1.32-2.22).

Higher-volume hospitals were more likely to use the endovascular approach. The highest-volume hospitals used the endovascular approach 44% of the time compared with only 18% at the lowest-volume hospitals. This greater use of the endovascular procedure at high-volume hospitals accounted for 37% of the difference in mortality between high-and low-volume hospitals. As the endovascular repair becomes more widespread, the relationship between hospital volume and operative mortality still remains,” wrote J.B. Dimick and colleagues…

The researchers concluded: “High-volume hospitals are more likely to use the endovascular approach, and this explains a significant portion of the observed impact of hospital volume on mortality…

Boston Scientific > Loses bid > Drug-treated heart stents > No new patent trial > Patent-infringement case > Dr Bruce N Saffran sued the company > Jury awarding Saffran $432 million > Adding $69 million for interest on royalties

Is the verdict is supported by both the evidence and the law? Will Boston Scientific prevail on appeal? Did the judge make prejudicial comments in front of the jury about the conduct of the company’s lawyers?

IIP > read on here > http://www.boston.com…

…A federal judge rejected a request by Boston Scientific Corp. for a new trial in a patent-infringement case that ended with a $501 million judgment against the medical-device maker.

Boston Scientific said it planned to appeal Wednesday’s ruling by U.S. District Judge T. John Ward in a case involving the company’s drug-treated heart stents.

Dr. Bruce N. Saffran sued the company, claiming that its stents infringed on his 1997 patent covering technology to deliver injury-healing medication inside the body.

Heart stents are mesh-wire tubes that prop open coronary arteries after surgery to remove fatty plaque.

In February, a jury in Marshall that sat through a one-week trial deliberated less than two hours before awarding Saffran $432 million. Ward later raised the amount by adding $69 million for interest on royalties dating to 2004, when Boston Scientific introduced the stents in the United States.

One of Saffran’s lawyers, Gary Hoffman, said the judge’s ruling supported the view that the jury “weighed the evidence on damages and that there was no basis whatsoever” to reduce the award.

Boston Scientific spokesman Paul Donovan said the Natick, Mass.-based company planned to appeal…

Boston Scientific based its motion for a new trial partly on the claim that the judge made prejudicial comments in front of the jury about the conduct of the company’s lawyers.

Ward wrote that the lawyers repeatedly broke his rules by such tactics as trying to elicit improper testimony from witnesses. In seeking a new trial, he wrote, the company was distorting the record of what happened during the trial.

Drug-coated stents are designed to prevent post-surgical scar tissue from creating new blockages in coronary arteries.

Boston Scientific argued that Saffran’s patent differed in design from its Taxus stent. It argued Saffran’s invention was insignificant and that more than 100 companies had declined to pay a license to use it. Boston Scientific and a unit of Johnson & Johnson dominate the market for newer stents.

Saffran, a radiologist from Princeton, N.J., also sued Johnson & Johnson. That case is pending in the same east Texas district, which attracts many patent claims because of its quick handling of cases and reputation for favoring plaintiffs…

Surgeons Use new NOTES devices > Complete Live Incisionless Appendectomy > NOTES Conference San Francisco > USGI Medical’s EndoSurgical Operating System > Successful Gastrotomy Closure Technique > Overcomes Main Hurdle > Widespread Adoption of Incisionless NOTES Surgery

Does the ability to close a gastrotomy safely and securely from inside the stomach represent a major leap forward in Incisionless surgery? Will USGI’s products enable surgeons to perform truly scarless NOTES procedures? Has incisionless surgery technology advanced significantly in recent years with expandable tissue anchors that fit across the full thickness of the stomach wall?

appendectomy.JPG

IIP > read on here > http://www.prnewswire.com…

…USGI Medical, Inc. (USGI) announced today that Santiago Horgan, M.D., director of the UC San Diego Center for the Future of Surgery, used the company’s EndoSurgical Operating System(TM) (EOS) to demonstrate a technique that allows for appendectomy without abdominal incisions at the Natural Orifice Surgery Consortium for Assessment and Research’s (NOSCAR) 3rd International Conference on Natural Orifice Translumenal Endoscopic Surgery(TM) (NOTES(TM)).

Horgan removed an appendix and then fully closed the stomach incision (the gastrotomy) from inside the stomach in front of the meeting’s 300 attendees on Saturday. The NOSCAR meeting took place in San Francisco, July 10 to 12.

Horgan became the first surgeon in the U.S. to remove a patient’s appendix through the mouth in late March, his 22nd “incisionless surgery” procedure. In later cases, he used USGI’s EOS to close the gastrotomy through the patient’s mouth following a NOTES appendectomy, another U.S. first.

The ability to close the gastrotomy from inside the stomach is considered the major hurdle to the widespread adoption of Incisionless NOTES surgery…

NOTES involves passing surgical instruments through one of the body’s natural orifices, such as the mouth or vagina, to remove a diseased organ such as an appendix or gallbladder. Operating solely through the body’s natural orifices eliminates external incisions and offers promise for less pain, shorter hospital stays, lower healthcare costs and no external scars compared to traditional and laparoscopic surgery…

Dr Michael E DeBakey > Father of modern cardiovascular surgery > Pioneering artificial heart > Dies at 99

Is he considered to be the greatest surgeon ever? Will we ever know how Cooley obtained the artificial heart from DeBakey’s lab? Was the DeBakey-Cooley feud necessary in order to focus on the clinical need for a total artificial heart?

debakey.JPG

IIP > read on here > http://www.thehindubusinessline.com…

…Dr Michael DeBakey, the pioneering heart surgeon who shot to fame for his procedures developing bypass surgery, has died at the age of 99.

Internationally acclaimed as the father of modern cardiovascular surgery and considered by many to be the greatest surgeon ever, Dr DeBackey died of “natural causes” last night, according to a written statement issued today by the spokesmen for Baylor Co llege of Medicine and The Methodist Hospital.

DeBakey underwent surgery in February 2006 for a damaged aorta - a procedure he had developed. Medical statesman, chancellor emeritus of Baylor College of Medicine and a surgeon at The Methodist Hospital since 1949, Dr DeBakey trained thousands of surgeo ns who now are practising throughout the world.

During his illustrious career spanning over 70 year, he is estimated to have performed more than 60,000 operations. His patients include late American presidents John F Kennedy, Russian President Boris Yeltsin among others.

A pioneer in the development of artificial hearts and heart pumps, Dr DeBakey helped to design dozens of surgical instruments, including the roller pump, part of the heart-lung machine.

Dr DeBakey was born in September 7 1908, in Lake Charles, Louisiana, to Lebanese immigrants. He got interested in medicine while listening to physicians chat at his father’s pharmacy.

Dr DeBakey’s first wife, Diana Cooper DeBakey, died of a heart attack in 1972. Three years later, he married a German film actress, Katrin Fehlhaber. She survives, along with their daughter, Olga-Katarina, and two of his four sons from his first marriage , Michael and Dennis…